Frederique Ponchel

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice.

T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice.

Journal: Rheumatology (Oxford, England)

Published: February 11, 2026

DNA hypo-methylation of the TNFΑ gene predicts response to methotrexate in rheumatoid arthritis but not in psoriatic arthritis.

DNA hypo-methylation of the TNFΑ gene predicts response to methotrexate in rheumatoid arthritis but not in psoriatic arthritis.

Journal: Rheumatology (Oxford, England)

Published: December 17, 2025

Methotrexate for Osteoarthritis: What Does the Evidence Say?

Methotrexate for Osteoarthritis: What Does the Evidence Say?

Journal: Drugs & aging

Published: September 05, 2025

Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study.

Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study.

Journal: Journal of pain research

Published: May 07, 2024

DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms.

DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms.

Journal: Cells

Published: August 17, 2023

Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.

Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.

Journal: Annals of internal medicine

Published: July 31, 2023

Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy.

Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy.

Journal: ACR open rheumatology

Published: July 02, 2023

Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals.

Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals.

Journal: Rheumatology (Oxford, England)

Published: March 10, 2023

B-cell capacity for expansion and differentiation into plasma cells are altered in osteoarthritis.

B-cell capacity for expansion and differentiation into plasma cells are altered in osteoarthritis.

Journal: Osteoarthritis and cartilage

Published: October 25, 2022

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.

Journal: RMD open

Published: June 15, 2022

Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?

Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?

Journal: Clinical and experimental rheumatology

Published: January 23, 2022

Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis.

Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis.

Journal: Clinical and experimental rheumatology

Published: December 16, 2021

Showing 1-12 of 54

Last Updated: 09/26/2026